The Insulin manufacturing facility is Asia’s largest Insulin production facility which utilizes Pichia pastoris as the expression system. The plant has a total installed capacity of about 130,000 litres of fermentation volume and is customized to suit the production of Insulin and Insulin analogs.
The Purification suite is equipped with new-generation purification equipment of Industrial scale with advanced levels of control. The Preparative scale chromatography skids, which are the heart of the purification process, are one of the largest in the country to be utilized for purification of therapeutic proteins. The facility is staffed with well-trained and skilled technical supervisors to manage the high-tech production operations.
The facility has been exposed to regulatory inspections from EU, USFDA and regulatory agencies from emerging countries and complies with their regulatory specifications.